Health Care: Drugs

Lexicon Pharmaceuticals Inc (LXRX: NASDAQ)

$1.44 n/a | n/a%
10/30/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 2.22M 1.09M 1.85M 4.91M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 2.22M 1.09M 1.85M 4.91M
Selling, General, and Administrative Expenses 17.12M 17.04M 17.35M 22.57M
Research & Development 89.68M 82.57M 91.83M 75.35M
Operating Income before D & A (EBITDA) -104.58M -98.53M -107.33M -93.01M
Depreciation & Amortization 2.86M 4.19M 4.89M 9.35M
Interest Income 157.00K 213.00K 255.00K 519.00K
Other Income - Net 59.00K -9.78M -6.61M -6.59M
Special Income / Charges 2.21M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -105.02M -112.29M -118.57M -108.43M
Interest Expense 1.97M 2.11M 2.53M 2.72M
Pre-Tax Income -106.99M -114.40M -121.10M -111.15M
Income Taxes 0.00 0.00 0.00 -26.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -104.13M -110.21M -116.22M -101.78M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -104.13M -110.21M -116.22M -101.78M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -104.13M -110.21M -116.22M -101.78M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-106.34M -110.21M -116.22M -101.78M
Preferred Dividends
Net Income Available To Common -104.13M -110.21M -116.22M -101.78M
Basic EPS from Continuing Ops. -0.20 -0.23 -0.34 -0.34
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.20 -0.23 -0.34 -0.34
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.20 -0.23 -0.34 -0.34
Basic Normalized Net Income/Share -0.21 -0.23 -0.34 -0.34
EPS fr Continuing Ops. -0.20 -0.23 -0.34 -0.34
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.20 -0.23 -0.34 -0.34
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.20 -0.23 -0.34 -0.34
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.21 -0.23 -0.34 -0.34
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LXRX

Latest LXRX Headlines from TheStreet

More Financial News for LXRX

Press Releases for LXRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter